O

Odonate Therapeutics Inc
OTC:ODTC

Watchlist Manager
Odonate Therapeutics Inc
OTC:ODTC
Watchlist
Price: 50 000 USD Market Closed
Market Cap: 52.7m USD

Relative Value

There is not enough data to reliably calculate the relative value of ODTC.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ODTC Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.3
Industry
21.4
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.4
Industry
16.4
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.4
Industry
22.8
vs History
vs Industry
Median 3Y
1.8
Median 5Y
1.8
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
13
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
16.5
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.4
Industry
15.6
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.4
Industry
18.7
vs History
vs Industry
Median 3Y
-34.2
Median 5Y
-34.2
Industry
1.9

Multiples Across Competitors

ODTC Competitors Multiples
Odonate Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Odonate Therapeutics Inc
OTC:ODTC
52.7m USD 0 -0.5 0.5 0.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
259.1B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
208.8B GBP 4.8 30 108.3 158.5
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
CH
Novartis AG
SIX:NOVN
207.2B CHF 4.7 18.2 11.5 14.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.8 14.5 10.1 11.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
O
Odonate Therapeutics Inc
OTC:ODTC
Average P/E: 24.2
Negative Multiple: -0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
37%
0.8
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
14.5
3%
4.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
O
Odonate Therapeutics Inc
OTC:ODTC
Average EV/EBITDA: 399.8
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.1
1%
10.1
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
O
Odonate Therapeutics Inc
OTC:ODTC
Average EV/EBIT: 1 712.2
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5